Picture of Pliant Therapeutics logo

PLRX — Pliant Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Pliant Therapeutics Q3 Net Income USD -57.763 Million Vs. IBES Estimate USD -59.3 Million

Nov 07 (Reuters) - Pliant Therapeutics Q3 operating expenses USD -62.014
million.
* Q3 operating income USD -62.014 million vs. IBES estimate USD -61.8 million

Recent news on Pliant Therapeutics

See all news